Radiology – Intervention

Review | Interventional gastroenterology in oncology.

12 Dec, 2022 | 12:46h | UTC

Interventional gastroenterology in oncology – CA: A Cancer Journal for Clinicians

 

---

Single-arm Study | Extended focal ablation of localized prostate cancer with high-frequency irreversible electroporation.

11 Jul, 2022 | 11:56h | UTC

Extended Focal Ablation of Localized Prostate Cancer With High-Frequency Irreversible Electroporation: A Nonrandomized Controlled Trial – JAMA Surgery (link to abstract – $ for full-text)

Commentary: Novel Focal Therapy Yields Low Rate of Serious Prostate Cancers — Trial’s 6-month rate of 6% was superior to historical control – MedPage Today (free registration required)

Related: Small study shows feasibility of MRI-guided focused ultrasound ablation for localized intermediate-risk prostate cancer

 

Commentary on Twitter

This single-arm objective performance criteria trial indicated excellent efficacy and safety profile of the second-generation high-frequency irreversible electroporation as primary treatment for localized prostate cancer. https://t.co/FheqcxJeA5

— JAMA Surgery (@JAMASurgery) July 7, 2022

 

---

Consensus Recommendations: Early management of patients with aneurysmal subarachnoid hemorrhage in a hospital with neurosurgical/neuroendovascular facilities.

22 Jun, 2022 | 11:25h | UTC

Part 1: Early management of patients with aneurysmal subarachnoid hemorrhage in a hospital with neurosurgical/neuroendovascular facilities: a consensus and clinical recommendations of the Italian Society of Anesthesia and Intensive Care (SIAARTI)–Part 1 – Journal of Anesthesia, Analgesia and Critical Care

Part 2: Early management of patients with aneurysmal subarachnoid hemorrhage in a hospital with neurosurgical/neuroendovascular facilities: a consensus and clinical recommendations of the Italian Society of Anesthesia and Intensive Care (SIAARTI)—part 2 – Journal of Anesthesia, Analgesia and Critical Care

 

---

Single-arm phase 2b study: MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer.

20 Jun, 2022 | 00:56h | UTC

MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study – The Lancet Oncology (link to abstract – $ for full-text)

News Release: High-intensity focused ultrasound (HIFU) can control prostate cancer with fewer side effects – Memorial Sloan Kettering Cancer Center

 

Commentary on Twitter

In single-arm phase IIb trial of MRI-guided focused ultrasound therapy in 101 men with primary, group 2‒3 intermediate-risk untreated prostate adenocarcinomas, 88% had no evidence of group ≥2 prostate cancer in the treated area at 2 years: https://t.co/xLpqfFm8Ds #PCSM

— NatureRevClinOncol (@NatRevClinOncol) June 16, 2022

 

---

M-A: Comparison of radiofrequency ablation vs. cryoablation For T1 renal tumors.

18 May, 2022 | 10:25h | UTC

Comparison of Radiofrequency Ablation Versus Cryoablation For T1 Renal Tumors: An Evidence-Based Analysis of Comparative Outcomes – Frontiers in Oncology

 

---

Update on image-guided thermal lung ablation: Society guidelines, therapeutic alternatives, and postablation imaging findings.

4 May, 2022 | 08:14h | UTC

Update on Image-Guided Thermal Lung Ablation: Society Guidelines, Therapeutic Alternatives, and Postablation Imaging Findings – American Journal of Roentgenology

 

---

Consensus Statement | Minimally-invasive treatments for benign thyroid nodules: recommendations for information to patients and referring physicians.

24 Mar, 2022 | 08:42h | UTC

Minimally-invasive treatments for benign thyroid nodules: recommendations for information to patients and referring physicians by the Italian Minimally-Invasive Treatments of the Thyroid group – Endocrine

 

---

Summary: German evidence-based guidelines on focal therapy in localized prostate cancer.

17 Mar, 2022 | 08:47h | UTC

German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy – Urologia Internationalis

 

---

RCT: Neurolytic splanchnic nerve block and pain relief, survival, and quality of life in unresectable pancreatic cancer.

30 Sep, 2021 | 10:16h | UTC

Neurolytic Splanchnic Nerve Block and Pain Relief, Survival, and Quality of Life in Unresectable Pancreatic Cancer: A Randomized Controlled Trial – Anesthesiology

 

Commentary on Twitter

Neurolytic Splanchnic Nerve Block and Pain Relief, Survival, and Quality of Life in Unresectable Pancreatic Cancer: A Randomized Controlled Trial https://t.co/xa9sPAdQu1 pic.twitter.com/gi74fdDSfl

— Anesthesiology journal (@_Anesthesiology) August 30, 2021

 

---

Consensus paper: Clinical indications for image-guided interventional procedures in the musculoskeletal system—part V, knee.

23 Sep, 2021 | 09:59h | UTC

Clinical indications for image-guided interventional procedures in the musculoskeletal system: a Delphi-based consensus paper from the European Society of Musculoskeletal Radiology (ESSR)—part V, knee – European Radiology

See other articles in the series: Consensus paper: Clinical indications for image-guided interventional procedures in the musculoskeletal system.

 

---

Complications of renal interventions: a pictorial review of CT findings.

21 Jul, 2021 | 10:24h | UTC

Complications of renal interventions: a pictorial review of CT findings – Insights into Imaging

 

---

Systematic review: Treatments for unruptured intracranial aneurysms – There is currently insufficient good-quality evidence to support either conservative treatment or interventional treatments (microsurgical clipping or endovascular coiling)

13 May, 2021 | 05:51h | UTC

Treatments for unruptured intracranial aneurysms – Cochrane Library

Summary: Treatments for unruptured intracranial aneurysms – Cochrane Library

 

---

Review: Diagnosis and treatment of unruptured intracranial aneurysms and aneurysmal subarachnoid hemorrhage

13 May, 2021 | 05:53h | UTC

Diagnosis and Treatment of Unruptured Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage – Mayo Clinic Proceedings

 

---

M-A: Nonantibiotic Strategies for the Prevention of Infectious Complications following Prostate Biopsy

18 Apr, 2021 | 21:14h | UTC

Nonantibiotic Strategies for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis – The Journal of Urology

 

---

RCT: MRI-targeted biopsy safely reduces the need for biopsy in more than one-third of men at risk for prostate cancer

5 Feb, 2021 | 01:27h | UTC

Comparison of Multiparametric Magnetic Resonance Imaging–Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial – JAMA Oncology

Commentary: Clinical trial: Using MRI for prostate cancer diagnosis equals or beats current standard – Ontario Institute for Cancer Research AND Another Win for MRI and Targeted Prostate Biopsy – MedPage Today (free registration required)

Related: MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis – New England Journal of Medicine (study and commentaries) Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis – European Urology AND Meta-Analysis: MRI plus Targeted Biopsy vs. Systematic Biopsy Alone for the Diagnosis of Prostate Cancer (studies and commentaries)

 

---